Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Mesa Laboratories (MLAB) EBIT (2016 - 2025)

Historic EBIT for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to $8.0 million.

  • Mesa Laboratories' EBIT rose 3799.97% to $8.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $17.2 million, marking a year-over-year increase of 10672.03%. This contributed to the annual value of $16.3 million for FY2025, which is 10600.42% up from last year.
  • Per Mesa Laboratories' latest filing, its EBIT stood at $8.0 million for Q4 2025, which was up 3799.97% from $4.7 million recorded in Q3 2025.
  • Mesa Laboratories' EBIT's 5-year high stood at $8.0 million during Q4 2025, with a 5-year trough of -$271.3 million in Q1 2024.
  • Its 5-year average for EBIT is -$11.4 million, with a median of $3.1 million in 2021.
  • Over the last 5 years, Mesa Laboratories' EBIT had its largest YoY gain of 872537.31% in 2024, and its largest YoY loss of 5257272.73% in 2024.
  • Mesa Laboratories' EBIT (Quarter) stood at -$2.5 million in 2021, then skyrocketed by 235.43% to $3.4 million in 2022, then crashed by 101.97% to -$67000.0 in 2023, then skyrocketed by 8725.37% to $5.8 million in 2024, then soared by 38.0% to $8.0 million in 2025.
  • Its EBIT was $8.0 million in Q4 2025, compared to $4.7 million in Q3 2025 and $3.1 million in Q2 2025.